InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the complete record of transactions filed by Aklog Lishan. Director active across 2 companies, notably Lucid Diagnostics Inc.. Cumulatively, 7 disclosures have been logged. History available since 7 January 2022. The latest transaction was filed on 2 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Aklog Lishan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
350,000 shares0Common StockSEC:0001094891-26-000165:0
2,170,000 shares0Common StockSEC:0001094891-26-000083:0
150,000 shares0Common StockSEC:0001094891-25-000039:0
300,000 shares0Common StockSEC:0001062993-25-003218:0
400,000 shares0Common stockSEC:0001062993-24-009637:0
79,636 shares@ US$1.180.19% mcap100.0% of flowCommon stockSEC:0001062993-22-010063:0
60,000 shares0Common stockSEC:0001062993-22-000907:0
7 of 7 declarations
About Aklog Lishan
Aklog Lishan is Chief Executive Officer at Lucid Diagnostics Inc. and Chairman and CEO at PAVmed Inc. The declarant has 6 filings in total, and the 6 sampled filings run from 2022-01-10 to 2026-02-24. The modal transaction nature is Attribution, with sum_buy_eur at 0 and sum_sell_eur at 0 across the sampled recent filings.
